BioNTech
BioNTech is a Mainz-based biotechnology company that pioneered the use of messenger RNA (mRNA) technology in human therapeutics. Best known for co-developing Comirnaty, the COVID-19 mRNA vaccine with Pfizer, BioNTech is building a broad oncology pipeline across mRNA cancer immunotherapies, next-generation immunomodulators such as the bispecific antibody BNT327, and targeted therapies, as well as continuing infectious disease vaccine development. BioNTech does not currently expose a public developer API; this index captures the company's products, pipeline, clinical trials, and corporate resources as an API Evangelist profile.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles BioNTech the way a machine reads it — 12 machine-readable artifacts, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — BioNTech scores 14.3/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile BioNTech
Each block below is one kind of artifact we hold for BioNTech. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Features 6
The notable capabilities this provider advertises, captured as structured features so they can be searched and compared instead of read one landing page at a time.
Notable capabilities this provider offers.
mRNA Platform
Proprietary messenger RNA platform underlying Comirnaty and the company's broader vaccine and oncology pipeline
Comirnaty
COVID-19 mRNA vaccine co-developed and commercialized in collaboration with Pfizer
Oncology Pipeline
Three complementary modalities across mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies
BNT327
Next-generation bispecific antibody candidate binding PD-L1 and VEGF-A for synergistic cancer treatment
mRNA Cancer Immunotherapies
Individualized neoantigen cancer immunotherapies targeting residual tumor cells in adjuvant settings
Infectious Diseases Pipeline
Vaccine candidates extending the mRNA platform to additional high-burden infectious diseases
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Use Cases 4
What developers actually build with this provider — captured so the catalogue answers 'what is this for', not just 'what does this expose'.
What developers build with this provider.
COVID-19 Vaccination
Continued supply of Comirnaty COVID-19 vaccine across global markets
Cancer Immunotherapy
25+ Phase 2/3 oncology clinical trials and 10+ novel combination trials
Pandemic Preparedness
Application of mRNA platform to rapidly developable vaccines against emerging infectious disease threats
Healthcare Professional Information
Dedicated medical affairs portal providing scientific and clinical data to clinicians
Integrations 1
Pre-built integrations with other platforms tell you where this provider already fits in a stack.
Pre-built integrations with other platforms and tools.
Pfizer Collaboration
Long-running co-development and commercialization partnership for Comirnaty and other mRNA programs
Resources
Every other property we hold for BioNTech — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Get Started 1
Portal, sign-up, and the first successful call
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 1
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/biontech · machine-readable index on apis.io